Phoenix Life Sciences International Receives Approval for Name Change, Symbol Change, and Completion of Consolidation of Businesses


Phoenix Life Sciences International Limited (OTC: PLSI) (Phoenix Life), an international adaptive healthcare solutions company, today announced it has completed the last stages the consolidation of businesses and received approval from the Financial Industry Regulatory Authority (FINRA) of the corporate action completing its name change and change of stock symbol. Phoenix Life Sciences International Limited will now trade under the stock symbol PLSI. After five years of planning and hard work, we could not be more excited to have completed this consolidation to build a world changing organization, said Martin Tindall, CEO of Phoenix Life Sciences International. This marks the end of what has been a long transitional period for our company and the beginning of a new chapter of opportunity for Phoenix Life. We have made incredible progress over the past months towards our goal of creating a truly international healthcare organization. Our focus on creating global supply of pharmaceutical and nutraceutical products derived from medical cannabis and other botanical compounds targeted towards treating patients across the world with a range of diseases makes me truly proud. The company has recently announced some of the following milestones: – Completion of merger including retiring all convertible notes – Appointment of new Board of Directors and executive team – Received approval to establish operations in the country and manufacture botanical pharmaceutical products – Medical Advisory Council adds Diabetes Director Tindall continued, Unlike other companies that are focused on retail or limited markets, our vision is to bring cannabinoid-based treatments to a global …

[Read on via official release]

Source: US SEC
View full document: